Koizumi Y
Nihon Sanka Fujinka Gakkai Zasshi. 1982 Sep;34(9):1539-48.
Plasma samples obtained by continuous withdrawal for a 10-hour period in normal menstrual cycle were assayed for human luteinizing hormone (hLH) by both the in vitro bioassay and improved radioimmunoassay (RIA). The pulsatile patterns of both biological and immunological hLH levels were demonstrated with high frequency and low amplitude in the follicular phase and with low frequency and high amplitude in the luteal phase in the present study, as seen in the literature, although the assay procedures were different. The basal levels of immunoreactive hLH were 17.99mIU/ml with 95% confidence limits at 14.49 and 22.34mIU/ ml in the follicular phase and 10.79 (6.62 : 17.58) mIU/ml in the luteal phase. These two values were comparable to those in the literature. On the other hand, those of bioreactive hLH in the corresponding phases were 21.68 (15.21 : 30.90) mIU/ml and 6.22 (4.94 : 7.83) mIU/ml, respectively. The differences of the basal levels in these two phases were more pronouncedly assessed by the bioassay than by the RIA. The ratios of biological to immunological hLH activities (B/I ratios) at the trough (base) were over the unity (1.21 (1.03 : 1.41) ) in the follicular phase, whereas those in the luteal phase were decreased down to 0.58 (0.44 : 0.76). This depression is likely due to the poor specificity of the antiserum employed in the RIA. The half disappearance times (t1/2's) of the immunoreactive hLH were shortened significantly in the preovulatory phase(83.7(64.3 : 103.1)min)in comparison with those of the bioreactive hLH(122.9(98.2 : 147.6) min). The B/I ratios at the peaks of the pulses were depressed down in the preovulatory phase. The possible existence of hLH with immunoactivity and no, or little, bioactivity was suggested from these two evidences in this stage of menstrual cycle. The difference in the t1/2's of bioreactive hLH in the follicular and luteal phase (103.6 (94.7 : 112.5) min and 87.2 (72.5 : 101.9) min, respectively) indicated proportional differences of hLH subpopulations with various clearance rates in these two phases.
在正常月经周期中,通过连续抽取10小时获得的血浆样本,采用体外生物测定法和改进的放射免疫测定法(RIA)对人促黄体生成素(hLH)进行了检测。在本研究中,生物活性和免疫活性hLH水平的脉冲模式在卵泡期呈现高频低幅,在黄体期呈现低频高幅,正如文献中所见,尽管检测方法不同。免疫反应性hLH的基础水平在卵泡期为17.99mIU/ml,95%置信区间为14.49至22.34mIU/ml,在黄体期为10.79(6.62:17.58)mIU/ml。这两个值与文献中的值相当。另一方面,相应阶段生物活性hLH的基础水平分别为21.68(15.21:30.90)mIU/ml和6.22(4.94:7.83)mIU/ml。与放射免疫测定法相比,生物测定法更能明显地评估这两个阶段基础水平的差异。卵泡期谷值(基础值)处生物活性与免疫活性hLH活性的比值(B/I比值)超过1(1.21(1.03:1.41)),而黄体期则降至0.58(0.44:0.76)。这种降低可能是由于放射免疫测定法中所用抗血清的特异性较差。与生物活性hLH(122.9(98.2:147.6)分钟)相比,免疫反应性hLH的半衰期(t1/2)在排卵前期显著缩短(83.7(64.3:103.1)分钟)。脉冲峰值处的B/I比值在排卵前期降低。从月经周期的这个阶段的这两个证据表明,可能存在具有免疫活性但无生物活性或生物活性很小的hLH。卵泡期和黄体期生物活性hLH的t1/2差异(分别为103.6(94.7:112.5)分钟和87.2(72.5:101.9)分钟)表明这两个阶段中具有不同清除率的hLH亚群存在比例差异。